Trial Profile
Quality of life and side effects in patients with actinic keratosis treated with ingenol mebutate.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 24 Aug 2015 New trial record